Genomics

Dataset Information

0

DNA-sequencing of baseline plasma from the phase III Alliance A031201 trial

ABSTRACT: DNA-sequencing of baseline plasma from the phase III Alliance A031201 trial

PROVIDER: PRJNA986278 | ENA |

REPOSITORIES: ENA

Json Xml

Similar Datasets

Genomics DNA-sequencing of baseline plasma from the phase III Alliance A031201 trial
| PRJNA986279 | ENA
Genomics Molecular Analysis of Alliance A031201 study
| PRJNA1138812 | ENA
Genomics Molecular Analysis of Alliance A031201 study
| PRJNA1138813 | ENA
Genomics Proteogenomic analysis of CALGB40601 (ALLIANCE) a neoadjuvant phase III HER2-positive breast cancer trial
| PRJNA1083656 | ENA
Genomics Proteogenomic analysis of CALGB40601 (ALLIANCE) a neoadjuvant phase III HER2-positive breast cancer trial
| PRJNA1083657 | ENA
Genomics NCTN: Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer (A031201)
| PRJNA1308194 | ENA
Genomics NCTN: Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer (A031201)
| PRJNA1308195 | ENA
Unknown Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201).
| S-EPMC11539927 | biostudies-literature
Genomics E96A baseline transcriptional changes
| PRJNA1370849 | ENA
Genomics HepG2 baseline cells from HULAFE
| PRJEB24464 | ENA